Effects of sustained-release oral phenylpropanolamine on the nasal mucosa of healthy subjects.
Phenylpropanolamine (PPA) is widely used as a nasal decongestant administered orally in sustained release preparations and, in Sweden, the recommended dose nowadays is 50 mg twice daily for adults. The aim of this placebo-controlled, cross-over study was to determine the onset and duration of the de...
| Publicado en: | Acta Oto-Laryngologica Vol. 119; no. 7; pp. 837 - 843 |
|---|---|
| Autores principales: | , , , |
| Formato: | clinical trial research Journal Article |
| Publicado: |
Taylor & Francis Ltd
12/30/99
|
| Acceso en línea: | Ver este registro en EBSCOhost |